Awards

EAU awards 2013

Every year the EAU hands out a number of prestigious awards – to recognise and celebrate dedication and innovation in urological research and practice. Traditionally handed out at the Annual EAU Congress, the awards are a vital acknowledgement of the fact that the international urological community is progressive and continues to push the limits of what is known to mankind today.

Recognition Awards

EAU Willy Gregoir Medal 2013
C-C. Abbou, Creteil, France

EAU Frans Debruyne Life Time Achievement Award 2013
J. Breza
, Bratislava, Slovakia 

EAU Crystal Matula Award 2013
P. Boström
, Turku, Finland
Supported by an unrestricted educational grant from LABORIE

EAU Hans Marberger Award 2013
J. Rassweiler
, Heilbronn, Germany
iPad-Assisted Percutaneous Access to the Kidney Using Marker-Based Navigation: Initial Clinical Experience
M. Müller, M. Fangerau, J.Klein, A. Goezen, P. Pereira, H-P. Meinzer, D. Teber (Heilbronn, Germany)
European Urology (2012), doi 10.1016/j.eururo.2011.12.024
Supported by an unrestricted educational grant from the KARL STORZ GMBH CO.KG

EAU Innovators in Urology Award 2013
U. Studer
, Berne, Switzerland 

EAU Prostate Cancer Research Award 2013
I. Ahmad, Glasgow
, United Kingdom
HER2 overcomes PTEN (loss) - induced senescence to cause aggressive prostate cancer
R. Patel, L. Babloo Singh, C. Nixon, M. Seywright, R. Barnetson, V. Brunton, W. Muller, J. Edwards, O. Sansom, H. Leung (Glasgow, Edinburgh, United Kingdom; Montreal, Canada)
PNAS | September 27, 2011 | vol. 108 | no. 39 | 16397
Supported by an unrestricted educational grant from the FRITZ H. SCHRODER FOUNDATION

New EAU Honorary Members 2013
P. Rigatti, Milan, Italy
I. Sinescu, Bucharest, Romania
R. Umbas, Jakarta, Indonesia


Scientific Awards

Prize for the Best Paper published on Fundamental Research in the Urological Literature in 2012
E. Martens, S. Jalava, N. Dits, G. Van Leenders, S. Møller, J. Trapman, C. Bangma, T. Litman, T. Visakorpi, G. Jenster (Rotterdam, The Netherlands; Tampere, Finland; Vedbeak, Denmark)
Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer
Oncogene (2012) 31, 978-991 – doi: 10.1038/onc.2011.304

Prize for the Best Paper published on Clinical Research in the Urological Literature in 2012
S. Shariat, M. Rink, B. Ehdaie, E. Xylinas, M. Babjuk, A. Merseburger, R. Svatek, E. Cha, S. Tagawa, H. Fajkovic, G. Novara, P. Karakiewicz, Q-D. Trinh, S. Daneshmand, Y. Lotan, W. Kassouf, H-M. Fritsche, F. Chun, G. Sonpavde, A. Joual, D. Scherr, M. Gonen (New York, San Antonio, Los Angeles, Dallas, Houston, United States of America; Hamburg, Hanover, Regensburg, Germany; Paris, France; Prague, Czech Republic; Padua, Italy; Montreal, Canada; Casablanca, Morocco)
Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy
European Urology (2012) – accepted June 5, 2012 - doi: 10.1016/j.eururo.2012.06.008

Prize for the Best Scientific Paper published in European Urology in 2012
R. Rosenblatt, A. Sherif, E. Rintala, R. Wahlqvist, A. Ullén, S. Nilsson, P-U. Malmström, The Nordic Urothelial Cancer Group (Katrineholm, Stockholm, Uppsala, Sweden; Helsinki, Finland; Oslo, Norway)
Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer
European Urology, Volume 61, Issue 6, June 2012, Pages 1229-1238
Supported by an unrestricted educational grant from ELSEVIER

Prize for the Best Scientific Paper published on Fundamental Research in European Urology by a young urologist in 2012
R. Kandimalla, A. Van Tilborg, L. Kompier, D. Stumpel, R. Stam, C. Bangma, E. Zwarthoff (Rotterdam, The Netherlands)
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic Markers
European Urology, Volume 61, Issue 6, June 2012, Pages 1245-1256
Supported by an unrestricted educational grant from ELSEVIER

Prize for the Best Scientific Paper published on Clinical Research in European Urology by a young urologist in 2012
M. Rink, B. Ehdaie, E. Cha, D. Green, P. Karakiewicz, M. Babjuk, V. Margulis, J. Raman, R. Svatek, H. Fajkovic, R. Lee, G. Novara, J. Hansen, S. Daneshmand, Y. Lotan, W. Kassouf, H-M. Fritsche, A. Pycha, M. Fisch, D. Scherr, S. Shariat (New York, Dallas, Hershey, San Antonio, Los Angeles, Houston, United States of America; Hamburg, Regensburg, Germany; Montreal, Canada; Prague, Czech Republic; St. Poelten, Austria; Padua, Bolzano, Italy)
Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery
European Urology, Volume 62, Issue 4, October 2012, Pages 677-684

First Prize for the Best Abstract (Oncology)
J. Moll, R. Van Soest, J. Kumagai, R. Graeser, I. Hickson, G. Jenster, W. Van Weerden (Rotterdam, The Netherlands; Beerse Belgium) - Abstract 824
Abiraterone is able to block AR activation induced by accumulating levels of precursor hormones resulting from CYP17A1 inhibition

Second Prize for the Best Abstract (Oncology)
P. Sooriakumaran, L. Haendler, T. Nyberg, I. Heus, M. Olsson, S. Carlsson, M. Roobol, P. Wiklund (Stockholm, Sweden; Rotterdam, The Netherlands) - Abstract 912
Comparative oncologic effectiveness of radical prostatectomy and radiotherapy in prostate cancer: An analysis of mortality outcomes in 34,515 patients treated with up to 15 years follow-up

Third Prize for the Best Abstract (Oncology)
H. Uemura, T. Kimura, K. Yoshimura, T. Minami, M. Nozawa, T. Nakagawa, H. Fujimoto, S. Egawa, A. Yamada, K. Itoh (Osaka, Tokyo, Fukuoka, Japan) - Abstract 98
Combination therapy of peptide vaccines and dexamethasone for chemotherapy naïve castration resistant prostate cancer - a randomized phase-2 study

First Prize for the Best Abstract (Non-Oncology)
M. Lanz, C. Birchall, A. Ali, K. Walton, C.Townes, L. Lim, S. Roushias, P. Aldridge, R. Pickard, J. Hall (Newcastle Upon Tyne, United Kingdom) - Abstract 623
Bacterial motility and NF-êB activation by clinical isolates from urinary tract infections

Second Prize for the Best Abstract (Non-Oncology)
K. Filipski, K. Deckmann, T. Bschleipfer, G. Krasteva-Christ, T. Papadakis, A. Rafiq, M. Wolff, I. Ibanez-Tallon, B. Schütz, E. Weihe, W. Kummer  (Giessen, Berlin, Marburg, Germany) - Abstract 62
A new cell in the urogenital tract - cholinergic chemosensory brush cells are sentinels of the Urethra

Third Prize for the Best Abstract (Non-Oncology)
Y. Song, H. Lee, J. An, J. Yun, J. Kim, S. Doo, W. Yang, S. Kim (Seoul, South Korea) - Abstract 325
Repair of erectile dysfunction using transplantation of human mesenchymal stem cells cultivated on the surface of nanofibrous meshes in rats with cavernous nerve injury

First Prize for the Best Abstract by a resident
G. Shaw, D. Lewis, J. Boren, A. Ramos-Montoya, D. Soloviev, R. Bielik, K. Brindle, D. Neal (Cambridge, United Kingdom) - Abstract 833
Monitoring the effects of therapeutic fatty acid synthase inhibition in prostate canecr using 11C acetate PET

Second Prize for the Best Abstract by a resident
F. Castiglione, P. Hedlund, F. Van Der Aa, T. Bivalacqua, M. Albersen (Milan, Italy; Leuven, Belgium; Baltimore, United States of America) - Abstract 324
Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie’s disease

Third Prize for the Best Abstract by a resident
A. Ingels, A. Thong, M. Saar, M. Valta, R. Nolley, J. Santos, H. Zhao, D. Peehl  (Stanford, United States of America) - Abstract 975
Pre-clinical trial of a new dual mTOR inhibitor: INK128 for renal cell carcinoma

Resident’s Corner Award for the Best Scientific Paper published in European Urology®  by a resident (2 awards)
T. Hambrock, C. Hoeks, C. Hulsbergen-Van de Kaa, T. Scheenen, J. Fütterer, S. Bouwense, I. Van Oort, F. Schröder, H. Huisman, J.Barentsz (Nijmegen, Rotterdam, The Netherlands)
Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy Cohort
European Urology, Volume 61, Issue 1, January 2012, Pages 177-184

&

E. Cha, L-A. Tirsar, C. Schwentner, P. Christos, C. Mian, J. Hennenlotter, T. Martini, A. Stenzl, A. Pycha, S. Shariat, B. Schmitz-Dräger (New York, United States of America; Nürnberg, Tübingen, Germany; Bolzano, Italy)
Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study
European Urology, Volume 61, Issue 1, January 2012, Pages 185-192

First Prize for Best Video
O. Ukimura, A. De Castro Abreu, M. Nakamoto, S. Shoji, S. Leslie, A. Berger, A. Goh, M. Desai, M. Aron, I. Gill (Los Angeles, United States of America)  - Video: V79
Novel surgical tile-pro navigation with 3D prostate cancer model during robot-assisted radical prostatectomy

Second Prize for Best Video
A. Rao, R. Gray, H. Motiwala, M. Laniado, O. Karim (Wexham, United Kingdom) - Video: V78
Sequential occlusion angiography using contrast enhanced ultrasound scan (CEUS) demonstrating the avascular plane of Brodel: An adjunct to a novel technique of zero-ischaemia robot-assisted partial nephrectomy

Third Prize for Best Video
S. Crouzet (Lyon, France) - Video: V77
Alternative solution to current MIS robotic system

EUSP Best Scholar Award
L.F. Arenas Da Silva, Mullheim an der Ruhr, Germany
Urethral Reconstruction using tissue Engineering Techniques


EAU 2013 Prizes outside the EAU Programme

ESUI Vision Award for the most innovative imaging study published in urological literature in 2012
F.E. Lecouvet, Brussels, Belgium
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Supported by an unrestricted educational grant from HITACHI MEDICAL SYSTEMS EUROPE / HITACHI ALOKA MEDICAL

ESRU Campbell’s Challenge
J. Roth,  Klagenfurt, Austria

Best Booth AWARD 2013
Millennium: The TAKEDA Oncology Company

This site uses cookies. Read more about our privacy policy.